跳至主要内容
临床试验/EUCTR2015-000704-25-GB
EUCTR2015-000704-25-GB进行中(未招募)1 期

Prevention of Aortic Stenosis Pilot Trial - PAS Pilot Trial

Queen Mary University of London0 个研究点目标入组 72 人开始时间: 2018年5月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients invited to participate in the trial will be men and women aged 18 to 90 with mild to moderate aortic stenosis defined according to a peak trans-aortic valve doppler gradient of 2.0-4.0m/s.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 62

排除标准

  • Exclusions include
  • 1)Any inclusion not met.
  • 2) Contraindications, including a history of allergy to sevelamer, a history of hypophosphataemia or a history of bowel obstruction
  • 3) a requirement for phosphate binding drugs for other reasons
  • 4) a requirement for drugs that interact with phosphate binding drugs
  • 5) A history of lactose intolerance
  • 6) any illness judged to contra-indicate participation in the trial
  • 7) pregnant or breast feeding women

研究者

相似试验

Prevention of Aortic Stenosis pilot trial | 临床试验